FDA approves Eli Lilly’s weight loss drug to treat sleep apnea Zepbound was approved to treat adults with moderate to severe obstructive sleep apnea.

A sleep scientist and a sleep medicine and pulmonary medicine specialist explain what central sleep apnea is, common symptoms and how to treat it ...

People with both type 2 diabetes (T2D) and obstructive sleep apnea have a higher risk of death, but treatment with continuous ...

Sleep apnea can have long-term effects on your health, which is why a diagnosis and treatment is so important.

If you or a loved one has sleep apnea, you may be considering different treatment options. A new treatment you may hear about is Zepbound (tirzepatide). In December 2024, Zepbound became the first ...

FILE - A woman demonstrates how she puts on her sleep apnea breathing device at her home in Los Angeles Thursday, July 12, 2018. Tirzepatide, used to treat diabetes and obesity, can help with ...

The study found late nights and alcohol use are some of the ways that can lead to disruptions in breathing during sleep, and ...

New research shows obstructive sleep apnea severity increases 18% on weekends compared to weekdays. A sleep expert discusses ...

The weight loss drug Zepbound has become the first prescription medication approved to treat obstructive sleep apnea. The Food and Drug Administration on Friday authorized the use of Zepbound ...

FILE - A woman demonstrates how she puts on her sleep apnea breathing device at her home in Los Angeles Thursday, July 12, 2018. Tirzepatide, used to treat diabetes and obesity, can help with ...

The FDA said studies have shown that by aiding weight loss, Zepbound improves sleep apnea symptoms in some patients.